Table 3 Morpho-functional echocardiographic parameters of the study population according to glucose tolerance

LVDD, cm

dPW, cm

LVM, g

LVMI, g/m2

LVEF%

GLS%

TAPSE, mm

PAPs, mmHg

TAPSE/PAPS, mm/mmHg

E, m/sec

A, m/sec

E/A

E/e’

LAVI, ml/mq

5.1 ± 0.4

0.9 ± 0.1

183.5 ± 33.1

97.7 ± 16.7

60.0 ± 4.1

-19.5 ± 2.7

22.3 ± 2.6

29.4 ± 6.6

0.8 ± 0.2

0.7 ± 0.2

0.8 ± 0.2

0.9 ± 0.3

11.4 ± 2.8

31.2 ± 7.3

4.9 ± 0.4

0.9 ± 0.1

171.0 ± 31.0

91.2 ± 15.9

60.1 ± 4.1

-20.3 ± 2.7

23.0 ± 2.5

28.3 ± 6.9

0.9 ± 0.2

0.8 ± 0.2

0.8 ± 0.2

1.0 ± 0.3

10.6 ± 2.6

29.8 ± 7.1

5.1 ± 0.3

1.0 ± 0.1

188.0 ± 29.1

99.5 ± 13.8

60.0 ± 4.0

-19.1 ± 2.6

22.2 ± 2.6

29.9 ± 6.3

0.8 ± 0.2

0.7 ± 0.2

0.8 ± 0.2

0.9 ± 0.4

11.7 ± 2.6

31.7 ± 7.6

5.2 ± 0.4

1.0 ± 0.1

202.8 ± 33.1

108.4 ± 16.4

59.7 ± 4.1

-18.2 ± 2.5

21.1 ± 2.6

30.9 ± 7.0

0.7 ± 0.3

0.7 ± 0.1

0.9 ± 0.2

0.8 ± 0.2

12.8 ± 2.9

34.7 ± 6.3

< 0.0001^∑

< 0.0001

< 0.0001^§

< 0.0001^@

0.795

< 0.0001^#

< 0.0001

0.006

< 0.0001

< 0.0001

0.066

< 0.0001

< 0.0001

0.001^Ω